The study is one of the largest to date to compare different treatment options for fibromyalgia and is published in the journal PAIN. About 200,000 people in Sweden currently live with fibromyalgia, a ...

A tailored, low-intensity exercise program provides evidence of lasting relief and improved quality of life for people with ...

New York, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The global fibromyalgia treatment market is expected to reach USD 2.7 billion by 2032, growing at a CAGR of 7.0% from 2023 to 2033. The growth of the market ...

Patients living with fibromyalgia (FM)—a disease that predominantly affects women and is characterized by chronic pain, fatigue and brain fog—often find limited treatment options and a scarcity of ...

There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia, according to a study led by researchers at Karolinska ...

Please provide your email address to receive an email when new articles are posted on . Tonmya significantly reduced daily pain vs. placebo in a phase 3 trial in fibromyalgia. Fast track designation ...

Topline Data from a Registration-Enabling Phase 3 Clinical Trial is Due Later This Month. CHATHAM, NJ / ACCESSWIRE / December 14, 2023 / Fibromyalgia is a chronic disorder characterized by widespread ...

CHARLOTTESVILLE, Va., Jan. 31, 2023 /PRNewswire/ -- AMPEL BioSolutions today announces a breakthrough in precision and personalized medicine that could revolutionize the way doctors treat chronic pain ...

Patients with fibromyalgia who underwent transcutaneous electrical nerve stimulation demonstrated significant improvements in ...

Patients living with fibromyalgia (FM) -- a disease that predominantly affects women and is characterized by chronic pain, fatigue and brain fog -- often find limited treatment options and a scarcity ...